Cognition Therapeutics received grant support from the NIH segment on July 12, 2025, for a clinical study.
3 reports, 2 independent
Updated Nov 2
Gone quiet
- Reports
- 3
- Developments
- 1
- Repetition
- 67%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Cognition Therapeutics received grant support from the NIH segment on July 12, 2025, for a clinical study.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Cognition Therapeutics (United States)
company in Pittsburgh, United States
Nothing else this week.
-
National Institutes of Health
government organization in Shah Alam, Malaysia
Related events
- The Office of Management and Budget proposes changes to federal funding policies affecting the National Institutes of Health.
- NIH awarded grant funding to researchers Alex Makhnevich and Liron Sinvani.
- The National Institutes of Health provided $32 million in renewal funding to Washington University School of Medicine.
- The National Institutes of Health (NIH) awarded funding to a laboratory located in the South End neighborhood.
- NIH awarded a grant to North Park University on November 1, 2026.
Coverage
Newest first; wire copies grouped- manilatimes.net
- Insider MonkeyCognition Therapeutics, Inc. (CGTX) Retains Buy Rating on START Study Progress Cognition Therapeutics, Inc. (NASDAQ:CGTX) is among the fundamentally strong penny stocks to invest in. H.C. Wainwright
- Unknown outlet